Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:05 PM
Ignite Modification Date: 2025-12-24 @ 11:05 PM
NCT ID: NCT00033969
Eligibility Criteria: * INCLUSION CRITERIA * Male or female patients referred by their physician with the diagnosis of CRPS criteria as outlined by Stanton-Hicks et al. OR * Healthy volunteers will be screened according to the eligibility criteria as specified in the appendix (see Healthy Subject Eligibility). * Age restrictions: Patients and volunteers must be (Bullet)18 years of age at the time of enrollment. There is no upper limit for age of inclusion. * Good general health (other disease states could may confound the results see exclusion criteria) * Willing to have blood drawn * Willing to have behavioral measures * Willing to provide a directed medical history * There is expected to be a greater number of females than males being recruited to this study since there is a much higher occurrence of CRPS in women. Additionally, it is expected to be equal across all ethnic groups. However, we do not anticipate requiring any special recruiting strategies for specific gender or ethnic groups. EXCLUSION CRITERIA * Contraindication to blood screening * Advanced disease other than the CRPS (cardiovascular, liver, kidney disease ASA III or above excluding CRPS) that may cause a theoretical inclusion of samples resulting in confounding results. * Pregnant and lactating women. No exclusions will be made based on race, gender, or religion.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT00033969
Study Brief:
Protocol Section: NCT00033969